Gabriel Sica
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 55
- Lung Cancer Research Studies 27
- Cancer Immunotherapy and Biomarkers 14
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Lieping Chen (9 shared papers)Koji Tamada (7 shared papers)Gefeng Zhu (6 shared papers)Dallas B. Flies (6 shared papers)Taofeek K. Owonikoko (42 shared papers)Suresh S. Ramalingam (38 shared papers)Andrei I. Chapoval (3 shared papers)Fadlo R. Khuri (30 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Clinical Cancer Research (5 papers)Journal of Thoracic Oncology (5 papers)Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Gabriel Sica
93 papers receiving 6.8k citations
Gabriel Sica's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 4.0k
- Immunology 3.0k
- Cancer Research 768
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 2.0k
Countries citing papers authored by Gabriel Sica
This map shows the geographic impact of Gabriel Sica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Sica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Sica more than expected).
Fields of papers citing papers by Gabriel Sica
This network shows the impact of papers produced by Gabriel Sica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Sica. The network helps show where Gabriel Sica may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Sica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | B7-H3: A costimulatory molecule for T cell activation and IFN-γ production Hit paper breakdown → | 2001 | 828 |
| 2 | Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent Hit paper breakdown → | 2017 | 724 |
| 3 | Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients Hit paper breakdown → | 2017 | 582 |
| 4 | B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity Hit paper breakdown → | 2003 | 568 |
| 5 | 2010 | 274 | |
| 6 | 2000 | 269 | |
| 7 | 2009 | 260 | |
| 8 | 2003 | 207 | |
| 9 | 2001 | 185 | |
| 10 | 2017 | 181 | |
| 11 | 2019 | 174 | |
| 12 | 2013 | 147 | |
| 13 | 2018 | 139 | |
| 14 | 2013 | 129 | |
| 15 | 2014 | 102 | |
| 16 | 2020 | 100 | |
| 17 | 2013 | 99 | |
| 18 | 2015 | 96 | |
| 19 | 2008 | 90 | |
| 20 | 2011 | 83 |
About Gabriel Sica
Gabriel Sica is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 97 papers that have together received 6.9k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (27 papers), Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (14 papers), Neuroendocrine Tumor Research Advances (12 papers), Cancer Genomics and Diagnostics (11 papers), Immunotherapy and Immune Responses (11 papers), Cancer therapeutics and mechanisms (10 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Oncology (4.0k citations), Immunology (3.0k citations), Cancer Research (768 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Molecular Biology (2.0k citations). Gabriel Sica has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Lieping Chen, Koji Tamada, Gefeng Zhu, Dallas B. Flies, Taofeek K. Owonikoko, Suresh S. Ramalingam, Andrei I. Chapoval, Fadlo R. Khuri, Jian Ni and Haidong Dong. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Thoracic Oncology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.